No Prescription |
 |
 | ||
|
Benadryl Nighttime Genahist |
|
| ||
No Prescription » Prescription Drugs 2 » Benadryl Nighttime Genahist Diphenhydramine is an antihistamine used to relieve symptoms of allergy hay fever and the common cold. These symptoms include rash itching watery eyes itchy eyes/nose/throat cough runny nose and sneezing. It is also used to prevent and treat nausea vomiting and dizziness caused by motion sickness. Diphenhydramine can also be used to help you relax and fall asleep.This medication works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Its drying effects on such symptoms as watery eyes and runny nose are caused by blocking another natural substance made by your body (acetylcholine). Buy Benadryl Nighttime Genahist and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Benadryl Nighttime Genahist: Product Type: Prescription Drugs 2 Benadryl Nighttime ( Genahist Sominex Unisom Generic Diphenhydramine ) Benadryl Nighttime (Genahist Sominex Unisom Generic Diphenhydramine) Genahist Sominex Unisom Generic Diphenhydramine 100mg/5mL 200mL 100mL Genahist Sominex Unisom Generic Diphenhydramine Benadryl Nighttime
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
